Benign ovarian tumo and ovarian cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient is treatment-naive and does not receive any prior surgical treatment or adjuvant therapies such as radiotherapy or chemotherapy. 2.Patient has been pathologically diagnosed with ovarian benign or malignant tumor following surgical treatment. 3.Complete clinical case data; 4.Patient does not have other malignant tumors. 5.Patient has not get chronic infections, hematological disorders, or autoimmune diseases recently.
Exclusion criteria
Exclusion criteria: 1.Patient get inflammatory or infectious diseases and has recently received anti-infective treatment concurrently; 2.Patient get other primary malignant tumors concurrently. 3.Patient received anti-tumor treatment before surgery. 4.Patient is in pregnancy or lactation period. 5.Patient who severes hepatic or renal diseases, bone marrow or blood disorders, and autoimmune diseases that affect blood cell counts; 6.Patient who takies oral medications that affect platelet function, coagulation, or hemostasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HE4;CA125;Serum AMH;D-dimer; | — |
Countries
China
Contacts
Yuebei People’s Hospital